4-methyl-7-ethoxycoumarin has been researched along with warfarin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Kuhn, UD; Müller, D; Rost, M; Splinter, FK | 1 |
Gao, H; Wei, B; Yang, R; Yu, W | 1 |
Fujie, A; Hino, M; Kobayashi, M; Takase, S; Ueno, M; Yamashita, M | 1 |
Chen, Z; Fan, S; Feng, Y; Huang, C; Huang, X; Jiang, X; Li, F; Li, H; Wu, X; Yuan, J; Zhang, Y; Zhou, Z | 1 |
4 other study(ies) available for 4-methyl-7-ethoxycoumarin and warfarin
Article | Year |
---|---|
Induction of cytochrome P450 1A1 in rat liver slices by 7-ethoxycoumarin and 4-methyl-7-ethoxycoumarin.
Topics: Animals; beta-Naphthoflavone; Coumarins; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP2B1; Enzyme Induction; Gene Expression; Liver; Male; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 1998 |
[Determination of five coumarins in toys by high performance liquid chromatography-tandem mass spectrometry].
Topics: Chromatography, High Pressure Liquid; Coumarins; Play and Playthings; Tandem Mass Spectrometry | 2012 |
Enhanced oxidative activities of cytochrome P450Rhf from Rhodococcus sp. expressed using the hyper-inducible expression system.
Topics: Bacterial Proteins; Biotransformation; Coumarins; Cytochrome P-450 Enzyme System; Enzymes; Molecular Structure; Oxidation-Reduction; Plasmids; Rhodococcus; Streptomyces lividans; Substrate Specificity; Transcriptional Activation; Umbelliferones | 2014 |
Pepper component 7-ethoxy-4-methylcoumarin, a novel dopamine D2 receptor agonist, ameliorates experimental Parkinson's disease in mice and Caenorhabditis elegans.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Animals, Genetically Modified; Behavior, Animal; Caenorhabditis elegans; Cell Line; Coumarins; Disease Models, Animal; Dopamine Agonists; Humans; Locomotion; Male; Mice, Inbred C57BL; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Receptors, Dopamine D2 | 2021 |